CFO and Executive VP of NuVasive Inc. (NUVA, Financial) Kevin C Oboyle sells 2,185 shares of NUVA on 09/15/2009 at an average price of $42.25 a share.
NUVASIVE is a medical device company focused on the design development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery or MAS as well as a growing offering of cervical and motion preservation products. Nuvasive Inc. has a market cap of $1.59 billion; its shares were traded at around $42.29 with a P/E ratio of 169.2 and P/S ratio of 6.4.
Recent Trades of NuVasive Inc. by CEO:
Recent Trades of NuVasive Inc. by CFO:
Recent Trades of NuVasive Inc. by Directors and Officers:
NUVASIVE is a medical device company focused on the design development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery or MAS as well as a growing offering of cervical and motion preservation products. Nuvasive Inc. has a market cap of $1.59 billion; its shares were traded at around $42.29 with a P/E ratio of 169.2 and P/S ratio of 6.4.
Recent Trades of NuVasive Inc. by CEO:
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 shares of NUVA stock on 09/09/2009 at the average price of $39.11; the price of the stock has increased by 8.13% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 more shares of NUVA stock on 08/07/2009 at the average price of $42.43; the price of the stock has decreased by 0.33% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 more shares of NUVA stock on 07/08/2009 at the average price of $39.88; the price of the stock has increased by 6.04% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 more shares of NUVA stock on 07/08/2009 at the average price of $39.88; the price of the stock has increased by 6.04% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 more shares of NUVA stock on 06/05/2009 at the average price of $41.14; the price of the stock has increased by 2.8% since.
Recent Trades of NuVasive Inc. by CFO:
- Sell: CFO and Executive VP Kevin C Oboyle sold 8,152 shares of NUVA stock on 09/14/2009 at the average price of $41.99; the price of the stock has increased by 0.71% since.
- Sell: CFO and Executive VP Kevin C Oboyle sold 2,180 more shares of NUVA stock on 08/14/2009 at the average price of $40.97; the price of the stock has increased by 3.22% since.
- Sell: CFO and Executive VP Kevin C Oboyle sold 6,000 more shares of NUVA stock on 07/15/2009 at the average price of $40.26; the price of the stock has increased by 5.04% since.
- Sell: CFO and Executive VP Kevin C Oboyle sold 6,000 more shares of NUVA stock on 06/12/2009 at the average price of $42.67; the price of the stock has decreased by 0.89% since.
- Sell: CFO and Executive VP Kevin C Oboyle sold 6,000 more shares of NUVA stock on 05/14/2009 at the average price of $36; the price of the stock has increased by 17.47% since.
Recent Trades of NuVasive Inc. by Directors and Officers:
- Sell: President and COO Keith Valentine sold 8,639 shares of NUVA stock on 09/14/2009 at the average price of $41.96; the price of the stock has increased by 0.79% since.
- Sell: SVP and General Counsel Jason Hannon sold 1,831 shares of NUVA stock on 09/10/2009 at the average price of $41.57; the price of the stock has increased by 1.73% since.
- Sell: Senior V.P., U.S. Sales Jeffrey P Rydin sold 7,565 shares of NUVA stock on 08/26/2009 at the average price of $40.13; the price of the stock has increased by 5.38% since.
- Sell: EVP, Marketing and Development Patrick Miles sold 4,182 shares of NUVA stock on 08/24/2009 at the average price of $41.21; the price of the stock has increased by 2.62% since.
- Sell: President and COO Keith Valentine sold 6,126 shares of NUVA stock on 08/20/2009 at the average price of $40.52; the price of the stock has increased by 4.37% since.
